107 completed, 18 unknown, 16 active not recruiting, 16 recruiting. 119 Not applicable, 4 Phase 4, 3 Phase 1, 2 Phase 3, 1 Early Phase 1.
Follow DexCom, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuous Glucose Monitors (CGMs) and Readmission Rates Continuous Glucose Monitor, Control Group - Diabetes (DM) | Not applicable | Not yet recruiting | University of Maryland, Baltimore | 120 | 2026-06-18 | 2026-04-29 |
| Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW) Dexcom CGM (Continuous Glucose Monitor) - Diabetes | Not yet recruiting | DexCom, Inc. | 5000 | 2026-06-15 | 2026-07-02 | |
| Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction Automated Insulin Delivery (AID), AIDANET + Fully Closed Loop (FCL), AIDANET + Anticipatory Closed Loop (ACL) - Type 1 Diabetes (T1D) | Not applicable | Active not recruiting | Sue Brown | 20 | 2026-05-14 | 2026-11-02 |
| Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis UBLoop System - Type-1-Diabetes | Not applicable | Completed | University of Bern | 6 | 2026-01-21 | 2026-07-16 |
| Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness Dexcom Stelo real-time Continuous Glucose Monitor - Gestational Diabetes, Postpartum | Not yet recruiting | Oregon Health and Science University | 50 | 2026-01-01 | 2026-01-21 | |
| REAL-Fam Feasibility Study for Youth Diabetes Management REAL-Fam Occupational Therapy Family Coaching - Type 1 Diabetes | Not applicable | Active not recruiting | University of North Carolina, Chapel Hill | 16 | 2025-12-15 | 2026-08-13 |
| Acute Sauna Session and Glucose Control Infrared sauna session, Resting condition - Obesity & Overweight | Not applicable | Recruiting | University of Prince Edward Island | 15 | 2025-12-01 | 2026-04-09 |
| Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia Real-Time Continuous Glucose Monitoring - Type 2 Diabetes on Insulin | Phase 4 | Active not recruiting | DexCom, Inc. | 200 | 2025-11-24 | 2026-05-22 |
| The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy Intelligent telemonitoring, Telemonitoring - Type 2 Diabetes Treated With Insulin | Not applicable | Recruiting | Aalborg University Hospital | 51 | 2025-11-15 | 2026-02-09 |
| A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home) AIDANET + FCL, AIDANET + HCL, AIDANET in FCL-HCL-mixed mode - Type 1 Diabetes | Not applicable | Active not recruiting | Sue Brown | 40 | 2025-09-02 | 2026-09-16 |
| Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT CGM device - Metformin group, CGM device - Insulin group - Gestational Diabetes Mellitus, Pregnancy, High Risk | Withdrawn | Ohio State University | 2025-09-01 | 2025-10-28 | ||
| Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes Education, lifestyle counseling, and peer support - Type 2 Diabetes Mellitus - Poor Control | Recruiting | Whole Endo | 100 | 2025-08-01 | 2025-07-08 | |
| AIDANET Pediatrics Normal Glycemia Goal, Tight Glycemia Goal - Type 1 Diabetes | Not applicable | Active not recruiting | Mark D. DeBoer, MD, MSc., MCR | 42 | 2025-07-21 | 2026-06-01 |
| Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot Continuous glucose monitor, Oral Glucose Tolerance Test, Hemoglobin A1c - Gestational Diabetes, Hyperglycemia | Recruiting | Ohio State University | 20 | 2025-06-06 | 2026-10-16 | |
| CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Diabetes Treatment, Usual Care Group - Gestational Diabetes Mellitus in Pregnancy | Not applicable | Recruiting | Jaeb Center for Health Research | 6000 | 2025-05-27 | 2025-12-23 |
| A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes Dexcom G7 rtCGM, Capillary Blood glucose Testing (POC) - Type 1 Diabetes | Not applicable | Recruiting | Emory University | 100 | 2025-05-12 | 2025-10-08 |
| Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery Diabetes Mellitus, Type 1, Energy Metabolism | Completed | Lia Bally | 40 | 2025-05-09 | 2026-09-16 | |
| Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations Continuous glucose monitor (CGM) - Type 2 Diabetes Mellitus (T2DM) | Not applicable | Active not recruiting | Diabetes Solutions International | 40 | 2025-03-18 | 2026-08-17 |
| Night Owl Metabolism Timing of OGTT, Timing of Standardized Meal - PreDiabetes, Overweight | Not applicable | Recruiting | Johns Hopkins University | 70 | 2025-02-25 | 2026-05-11 |
| The YMCA Healthy Lifestyle Program for Prediabetes Real time continuous glucose monitor (Stelo) - PreDiabetes | Not applicable | Active not recruiting | Young Men's Christian Association of the Blue Water Area | 84 | 2025-02-17 | 2026-08-18 |
Showing 20 of 170. Sign in to see all of them.
Diabetes Mellitus, Type 1 (69) · Diabetes Mellitus (51) · Diabetes Mellitus, Type 2 (28) · Diabetes, Gestational (10) · Hyperglycemia (10) · Hypoglycemia (10) · Insulin Resistance (9) · Glucose Intolerance (4) · Prediabetic State (4) · Cardiovascular Diseases (3) · Motor Activity (3) · Pregnancy Complications (3) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Kidney Failure, Chronic (2)
Continuous Glucose Monitoring (23) · Pancreas, Artificial (7) · Blood Glucose Self-Monitoring (2) · Cognitive Behavioral Therapy (2) · Control Groups (2) · Insulin Infusion Systems (2) · (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1) · Blood Glucose (1) · Carbohydrates (1) · Diet, Carbohydrate-Restricted (1) · Drug Delivery Systems (1) · Educational Status (1) · Exenatide (1) · Glucagon (1) · Glucose Tolerance Test (1)
United States (134) · United Kingdom (9) · Canada (8) · France (3) · Netherlands (3) · Sweden (3) · Denmark (2) · Switzerland (2) · Austria (1) · Belgium (1) · Israel (1) · Italy (1) · Saudi Arabia (1) · South Korea (1)
David Price, MD (8) · Sue Brown, MD (6) · Marc Breton, PhD (4) · Chiara Fabris, PhD (3) · Karen Elkind-Hirsch, PhD (3) · Stacey M. Anderson, MD (3) · Sue A Brown, MD (3) · Boris P. Kovatchev, PhD (2) · Celeste Durnwald, MD (2) · Gregory Forlenza, MD (2) · Jeffrey Gonzalez, PhD (2) · Kristin Castorino, DO (2) · Marc D. Breton, Ph.D. (2) · Marcus Lind, MD, PhD (2) · Meaghan Stumpf, MD (2)
PMID 22688340, PMID 37067353, PMID 42459945, PMID 19243265, PMID 20022127, PMID 21278138, PMID 24168317, PMID 24702135, PMID 25262455, PMID 25594434, PMID 25961446, PMID 26068865, PMID 27208320, PMID 27734563, PMID 28118453, PMID 28118454, PMID 28389582, PMID 28616804, PMID 28711468, PMID 28828487, PMID 28855239, PMID 29608107, PMID 30036082, PMID 30305346, PMID 31099946, PMID 31618560, PMID 31779476, PMID 31916854, PMID 31937608, PMID 32144167, PMID 32641374, PMID 32694787, PMID 32723843, PMID 32846062, PMID 32864597, PMID 33006904, PMID 33155824, PMID 33199470, PMID 33216667, PMID 33226837, PMID 33257486, PMID 33355258, PMID 33404325, PMID 33689454, PMID 33855888, PMID 34077499, PMID 34089660, PMID 34115946, PMID 34115959, PMID 34524020
UC4DK108483 (6), R01DK085623 (2), R01DK129553 (2), DP3DK101055 (1), DP3DK106785 (1), DP3DK106826 (1), DP3DK106826-01 (1), K23AT011048 (1), P30CA046934 (1), R01DK124886 (1), R01DK129687 (1), R01DK133148 (1), R21DK085641 (1)